ISSN: 0268-1315

Journal Home

Journal Guideline

International Clinical Psychopharmacology Q2 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Clinical Psychopharmacology is a journal indexed in SJR in Psychiatry and Mental Health and Pharmacology (medical) with an H index of 98. It has an SJR impact factor of 0,621 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,621.

International Clinical Psychopharmacology focuses its scope in these topics and keywords: patients, treatment, benzodiazepines, safety, study, major, ii, hospitalized, german, fluoxetine, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (medical) (Q2) Psychiatry and Mental Health (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

International Clinical Psychopharmacology

0,621

SJR Impact factor

98

H Index

62

Total Docs (Last Year)

141

Total Docs (3 years)

2596

Total Refs

326

Total Cites (3 years)

135

Citable Docs (3 years)

2.1

Cites/Doc (2 years)

41.87

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Psychiatric Quarterly Q2
International Journal of Methods in Psychiatric Research Q2
Revista Brasileira de Psiquiatria Q2
International Review of Psychiatry Q2
Behavioral Medicine Q2

Compare this journals

Aims and Scope

Best articles by citations

Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review

Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia

Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder: a metaanalysis of randomized controlled trials

Tolerance to desvenlafaxine in rapid metabolizing depressed patients

No changes in striatal dopamine transporter in antidepressant-treated patients with major depression

Weight change during long-term treatment with lurasidone

Depression in medical illness

A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance

Therapy-resistant depression

Serotonin and anxiety: current models

Effect of moclobemide on the psychophysiology of sleep/wake cycles

Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients

SHOW MORE ARTICLES

Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder

Serotonin in panic disorder and social phobia

The clock-drawing test as a possible indicator of acute psychosis

The effect of nefazodone on clozapine plasma concentrations

Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740

A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders

Evaluation of naltrexone for dissociative symptoms in borderline personality disorder

A Double-Blind Multicentre Study of Paroxetine and Amitriptyline in Depressed Outpatients

Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis

Efficacy of metformin for prevention of weight gain in psychiatric populations

Adjunctive lisdexamfetamine in bipolar depression

Early intervention in psychosis